Health and Healthcare

Incyte : INCY

All Incyte Articles

136 Articles

Trey Thoelcke | Feb 12, 2014 at 6:50 AM EST

Short Sellers Shy Away From Biotechs

24/7 Wall St. has tracked the short interest in leading biotech and emerging pharmaceutical stocks. By and large, short sellers…

Paul Ausick | Feb 5, 2014 at 8:20 AM EST

Merck Earnings Fail to Dazzle, but the Company’s Story Remains Strong

Before the markets opened Wednesday morning, drug giant Merck & Co. reported fourth-quarter and full-year 2013 results that failed to…

Trey Thoelcke | Jan 29, 2014 at 8:15 AM EST

UBS Says Buy Top Biotech Stocks in Front of Earnings for Big Upside

Like many firms on Wall Street, the biotechnology team at UBS thinks that most of the top mega-cap and large…

Jon C. Ogg | Jan 14, 2014 at 8:15 AM EST

UBS Has Nine Biotech Buyout and Merger Candidates

The analysts at UBS are not only bullish on the biotechnology sector, they think there is a very distinct possibility…

Jon C. Ogg | Jan 8, 2014 at 8:10 AM EST

J.P. Morgan Top Biotechnology Stocks to Buy for 2014

Biotechnology was an incredible performer in 2013. The analysts at J.P. Morgan think that the huge outperformance may lessen going…

Jon C. Ogg | Nov 21, 2013 at 7:25 AM EST

Solid Biotech Stocks With the Best Revenue Growth for 2014

ThinkstockAny time investors look for companies growing sales the most, one area that almost always stands out is the up…

Trey Thoelcke | Oct 14, 2013 at 8:15 AM EDT

Jefferies Top Biotech Stocks to Buy

ThinkstockThe world of biotechnology investing is a constantly evolving and changing one. While disease for the most part does not…

Paul Ausick | Aug 21, 2013 at 4:24 PM EDT

Wednesday Closing Bell: Markets Open, Close Lower

August 21, 2013: Markets opened mixed this morning as traders and investors waited for the afternoon’s release of the July…

Jon C. Ogg | Jul 2, 2013 at 8:45 AM EDT

Which Biotech Stocks Are Buyout Targets After Onyx Pharmaceutical Rejects Amgen?

ThinkstockOn Friday after the market closed, biotech giant Amgen Inc. (NASDAQ: AMGN) made an unsolicited $120 per share bid for…

Paul Ausick | May 7, 2013 at 4:05 PM EDT

Closing Bell for Tuesday on Wall Street: Share Prices Push Indexes to All-Time Highs

U.S. equity markets opened higher this morning following an unexpected 0.25% cut in Australia’s key interest rate to a new…

Jon C. Ogg | May 7, 2013 at 8:35 AM EDT

Top Wall Street Analyst Downgrades: AIG, Coach, J.C. Penney and More

These are the top analyst downgrades, cautious research notes and stocks to sell from Wall Street for Tuesday, May 7,…

Jon C. Ogg | Mar 18, 2013 at 12:55 PM EDT

7 Active Trading Big Volume Spikes (CHTR, GLUU, INCY, JNPR, PCRX, SLCA, VCLK)

ThinkstockActive traders and more active investors looking for news lists of stocks to buy or other investing ideas often look…

Jon C. Ogg | Feb 28, 2013 at 12:50 PM EST

ETF Folly: Biotech ETFs, Nothing but Confusion

Thinkstock24/7 Wall St. has always wondered about the confusing universe of biotech exchange-traded funds (ETFs). Biotech stocks can rise or…

Paul Ausick | Jan 23, 2013 at 4:05 PM EST

24/7 Wall St. Closing Bell — January 23, 2013: Market Open Higher on Little News (COST, GE, VZ, F, INCY, AMD, CSX, GOOG, IBM, IGT, TXN, ABT, BHI, COH, GD, MCD, LCC, AAPL, AMGN, NFLX, SNDK, FFIV, NE, NVR, WDC, MMM, BMY, LMT, RYN, LUV, UNP, UAL, XRX, MAPP, AGN, NMRX, MCP)

U.S. equity markets opened higher this morning following a string of solid earnings reports yesterday and after markets closed last…

Jon C. Ogg | Jan 23, 2013 at 8:16 AM EST

Top Analyst Upgrades and Downgrades (ALU, BHI, COST, DOV, ELLI, F, GE, GOOG, HIG, INCY, IBM, NU, SPG, AMTD, VZ)

Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Wednesday.…

1 … 6 7 8 9 10

Incyte : INCY

All Incyte Articles

Short Sellers Shy Away From Biotechs

Merck Earnings Fail to Dazzle, but the Company’s Story Remains Strong

UBS Says Buy Top Biotech Stocks in Front of Earnings for Big Upside

UBS Has Nine Biotech Buyout and Merger Candidates

J.P. Morgan Top Biotechnology Stocks to Buy for 2014

Solid Biotech Stocks With the Best Revenue Growth for 2014

Jefferies Top Biotech Stocks to Buy

Wednesday Closing Bell: Markets Open, Close Lower

Which Biotech Stocks Are Buyout Targets After Onyx Pharmaceutical Rejects Amgen?

Closing Bell for Tuesday on Wall Street: Share Prices Push Indexes to All-Time Highs

Top Wall Street Analyst Downgrades: AIG, Coach, J.C. Penney and More

7 Active Trading Big Volume Spikes (CHTR, GLUU, INCY, JNPR, PCRX, SLCA, VCLK)

ETF Folly: Biotech ETFs, Nothing but Confusion

24/7 Wall St. Closing Bell — January 23, 2013: Market Open Higher on Little News (COST, GE, VZ, F, INCY, AMD, CSX, GOOG, IBM, IGT, TXN, ABT, BHI, COH, GD, MCD, LCC, AAPL, AMGN, NFLX, SNDK, FFIV, NE, NVR, WDC, MMM, BMY, LMT, RYN, LUV, UNP, UAL, XRX, MAPP, AGN, NMRX, MCP)

Top Analyst Upgrades and Downgrades (ALU, BHI, COST, DOV, ELLI, F, GE, GOOG, HIG, INCY, IBM, NU, SPG, AMTD, VZ)

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Amazon and Tesla Drive One-Third of FDIS as U.S. Spending Surges Despite Recession-Level Sentiment

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Incyte : INCY

All Incyte Articles

Short Sellers Shy Away From Biotechs

Merck Earnings Fail to Dazzle, but the Company’s Story Remains Strong

UBS Says Buy Top Biotech Stocks in Front of Earnings for Big Upside

UBS Has Nine Biotech Buyout and Merger Candidates

J.P. Morgan Top Biotechnology Stocks to Buy for 2014

Solid Biotech Stocks With the Best Revenue Growth for 2014

Jefferies Top Biotech Stocks to Buy

Wednesday Closing Bell: Markets Open, Close Lower

Which Biotech Stocks Are Buyout Targets After Onyx Pharmaceutical Rejects Amgen?

Closing Bell for Tuesday on Wall Street: Share Prices Push Indexes to All-Time Highs

Top Wall Street Analyst Downgrades: AIG, Coach, J.C. Penney and More

7 Active Trading Big Volume Spikes (CHTR, GLUU, INCY, JNPR, PCRX, SLCA, VCLK)

ETF Folly: Biotech ETFs, Nothing but Confusion

24/7 Wall St. Closing Bell — January 23, 2013: Market Open Higher on Little News (COST, GE, VZ, F, INCY, AMD, CSX, GOOG, IBM, IGT, TXN, ABT, BHI, COH, GD, MCD, LCC, AAPL, AMGN, NFLX, SNDK, FFIV, NE, NVR, WDC, MMM, BMY, LMT, RYN, LUV, UNP, UAL, XRX, MAPP, AGN, NMRX, MCP)

Top Analyst Upgrades and Downgrades (ALU, BHI, COST, DOV, ELLI, F, GE, GOOG, HIG, INCY, IBM, NU, SPG, AMTD, VZ)

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Amazon and Tesla Drive One-Third of FDIS as U.S. Spending Surges Despite Recession-Level Sentiment

Featured Reads

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s